← Browse by Condition
Medical Condition
pancreatic adenocarcinoma
Total Trials
11
Recruiting Now
11
Trial Phases
Phase 3, Phase 1, Phase 2, Phase 2
ClinicalMetric tracks all active clinical trials for pancreatic adenocarcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — pancreatic adenocarcinoma Clinical Trials
How many clinical trials are currently recruiting for pancreatic adenocarcinoma?
ClinicalMetric currently tracks 11 actively recruiting clinical trials for pancreatic adenocarcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for pancreatic adenocarcinoma?
pancreatic adenocarcinoma research spans Phase 1 (4 trials), Phase 2 (6 trials), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a pancreatic adenocarcinoma clinical trial?
Eligibility criteria for pancreatic adenocarcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 4
Phase 2 6
Phase 3 2
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06250972 Phase 3
Recruiting
Enrollment
210 pts
Location
China
Sponsor
Fudan University
NCT05000294 Phase 1, Phase 2
Recruiting
Enrollment
29 pts
Location
United States
Sponsor
University of Florida
NCT05624918 Phase 2
Recruiting
Enrollment
38 pts
Location
United States
Sponsor
Ashish Manne
NCT03384238 Phase 1, Phase 2
Recruiting
Enrollment
27 pts
Location
United States
Sponsor
George Poultsides
NCT07478523 Phase 2
Recruiting
Enrollment
120 pts
Location
France
Sponsor
University Hospital, Bordeaux
NCT06552078
Recruiting
Enrollment
2,000 pts
Location
Italy
Sponsor
IRCCS San Raffaele
NCT06095141 Phase 2, Phase 3
Recruiting
Enrollment
30 pts
Location
China
Sponsor
Fudan University
NCT06988150
Recruiting
Enrollment
100 pts
Location
United States
Sponsor
Cedars-Sinai Medical Center
NCT06026943
Recruiting
Enrollment
15 pts
Location
Italy
Sponsor
Alpha Tau Medical LTD.
NCT06024824 Phase 1, Phase 2
Recruiting
Enrollment
49 pts
Location
Ireland
Sponsor
Cancer Trials Ireland
NCT06896188 Phase 1
Recruiting
Enrollment
12 pts
Location
United States
Sponsor
Anwaar Saeed
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology